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Abstract
The Global Programme to Eliminate Lymphatic Filariasis has made significant progress
toward interrupting transmission of lymphatic filariasis (LF) through mass drug administra-
tion (MDA). Operational challenges in defining endpoints of elimination programs include
the need to determine appropriate post-MDA surveillance strategies. As humans are the
only reservoirs of LF parasites, one such strategy is molecular xenomonitoring (MX), the
detection of filarial DNA in mosquitoes using molecular methods (PCR), to provide an indi-
rect indicator of infected persons nearby. MX could potentially be used to evaluate program
success, provide support for decisions to stop MDA, and conduct post-MDA surveillance.
American Samoa has successfully completed MDA and passed WHO recommended
Transmission Assessment Surveys in 2011 and 2015, but recent studies using spatial anal-
ysis of antigen (Ag) and antibody (Ab) prevalence in adults (aged18 years) and entomo-
logical surveys showed evidence of possible ongoing transmission. This study evaluated
MX as a surveillance tool in American Samoa by linking village-level results of published
human and mosquito studies. Of 32 villages, seropositive persons for Og4C3 Ag were iden-
tified in 11 (34.4%), for Wb123 Ab in 18 (56.3%) and for Bm14 Ab in 27 (84.4%) of villages.
Village-level seroprevalence ranged from 0–33%, 0–67% and 0–100% for Og4C3 Ag,
Wb123 Ab and Bm14 Ab respectively. PCR-positive Aedes polynesiensis mosquitoes were
found in 15 (47%) villages, and their presence was significantly associated with seroposi-
tive persons for Og4C3 Ag (67% vs 6%, p<0.001) and Wb123 Ab (87% vs 29%, p = 0.001),
but not Bm14 Ab. In villages with persons seropositive for Og4C3 Ag and Wb123 Ab, PCR-
positive Ae. polynesiensis were found in 90.9% and 72.2% respectively. In villages without
seropositive persons for Og4C3 Ag or Wb123 Ab, PCR-positive Ae. polynesiensis were
also absent in 94.1% and 70.6% of villages respectively. Our study provides promising evi-
dence to support the potential usefulness of MX in post-MDA surveillance in an Aedes
transmission area in the Pacific Islands setting.
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Author Summary
Lymphatic filariasis (LF) is caused by infectionwith filarial worms that are transmitted by
mosquito bites. Globally, 36 million are disfigured and disabled by complications such as
severe swelling of the legs (elephantiasis) or scrotum (hydrocele). The Global Programme
to Eliminate LF (GPELF) aims to interrupt disease transmission through mass drug
administration (MDA), and to control illness and suffering in affected persons. Significant
progress has beenmade toward eliminating LF frommany parts of the world, including
the Pacific Islands. Current challenges of the GPELF include identification of any residual
hotspots of ongoing transmission, and effective strategies for early identification of any
resurgence of infections. As humans are the only reservoirs of LF parasites and mosquitoes
have short flight ranges, one such strategy is to monitor LF infection in mosquitoes as an
indicator of ongoing transmission nearby. Mosquito monitoring could potentially be used
to evaluate program success, provide support for decisions to stop MDA, and conduct
post-MDA surveillance.Our study evaluated mosquito monitoring as a surveillance tool
in American Samoa by linking village-level results of published studies of LF in humans
and mosquitoes, and provides promising evidence to support the potential usefulness of
mosquito monitoring in post-MDA surveillance the Pacific Islands.
Introduction
Lymphatic filariasis (LF) is a parasitic infection caused byWuchereria or Brugia species of hel-
minth worms, and transmitted by mosquito vectors includingAedes, Anopheles, Culex and
Mansonia species. Globally, an estimated 68 million people are currently affected, including 36
millionmicrofilaraemic persons and 36 million who are disabled or disfiguredwith complica-
tions such as severe lymphoedema, including elephantiasis and scrotal hydrocoeles [1]. The
Global Programme to Eliminate LF (GPELF) aims to eliminate the disease as a public health
problem by 2020 using two main strategies: i) to interrupt transmission throughmass drug
administration (MDA) and ii) to control morbidity and disability of affected persons. In the
Pacific Islands, the Pacific Programme to Eliminate LF (PacELF) was formed in 1999 as part of
GPELF to focus on 22 Pacific Island Countries and Territories (PICTs), which include>3000
islands and 8.6 million people [2].
The sustained success of elimination programs requires cost-effective assessment and moni-
toring after successful completion of MDA to determine whether there are any residual foci of
infection, and to detect potential resurgence in a timely manner. TheWHO currently recom-
mends post-MDA surveillanceusing transmission assessment surveys (TAS), which use critical
cut-off values of numbers of antigen-positive children aged 6–7 years to determine whether
transmission has been interrupted in defined evaluation units [3]. In Brugia transmission
areas, antibody positivity is used for TAS. Cut-off thresholds for passing TAS vary depending
on population size of the target group and the local species of filarial parasites and mosquito
vectors. For example, whereW. bancrofti is endemic, the target cut-off value is estimated based
on upper 95% confidence interval of<1% antigen prevalence if Aedes is the principal vector, or
<2% antigen prevalence if Anopheles or Culex predominate. TAS typically involve school-
based or community-based testing of 6–7 year old children. Community-based surveys are
often logistically challenging, particularly in developing countries with limited financial and
human resources. In some areas (e.g. most of the Pacific Islands), difficult access to dispersed
populations in remote islands provides additional challenges. Also, TAS typically use rapid
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antigen detection tests (Filarial Immunochromatographic Test (ICT) cards or Filarial Test
Strips [4]), which might have reduced sensitivity after many rounds of MDA [5,6]. TAS has
been widely used to inform important programmatic decisions including stopping or restarting
MDA, but recent studies suggest that in some settings (including American Samoa), TAS
might not be sufficiently sensitive for determining whether transmission has been interrupted
[7,8].
As elimination programs reach the endgame phases and antigen prevalence drops to very
low levels, increasingly sensitive tools and strategies will be required to efficiently detect any
evidence of ongoing transmission or resurgence. TheWHO and GPELF have identified a num-
ber of operational challenges and unanswered questions for elimination programs, including
the significance of residual microfilaraemia and antigenaemia in communities where the target
threshold level has been achieved throughMDA, identification of residual high-prevalence
areas and strategies for managing them, and the need for development of cost-effective strate-
gies for post-MDA surveillance [9]. As humans are the only reservoir forW. bancrofti para-
sites, one such strategy is to monitor mosquitoes for evidence of LF larval stages [10,11].
Dissection and microscopic examination of mosquitoes is time consuming and labour-inten-
sive, and cannot be routinely recommended for post-MDA surveillance for practical reasons.
With recent technological advances, LF molecular xenomonitoring (MX), the use of molecular
methods (PCR) to detect filarial DNA in mosquitoes, has been explored and promising results
are emerging [12,13]. PCR-positive mosquitoes provide an indirect indicator of the presence of
infected humans and possible ongoing transmission [10,14–16]. For example, considering that
the flight ranges of Ae. polynesiensismosquitoes are on the order of a hundred metres [17],
detection of PCR-positive mosquitoes in areas where these are the main vectors indicates that
infected persons are or were recently nearby. Molecular methods are also more sensitive than
manual dissection for detecting infections [18]. Studies have reported the ability of PCR to
detect one microfilaria in pools of 50–100 mosquitoes [19], and for at least 2 weeks after mos-
quitoes (both vector and non-vector) ingest microfilaria-positive blood [20], which is close to
the average life span of most mosquito species.
Molecular xenomonitoring has been found to be a potentially useful indicator of human LF
infections with different species of mosquito vectors in diverse settings including American
Samoa [11], French Polynesia [16], Egypt [12,21], Sri Lanka [8], Sierra Leone [22], and Ghana
[23]. Molecular xenomonitoring is therefore potentially useful for evaluating the success of
elimination programs, providing support for decisions to stop MDA, and conducting ongoing
post-MDA surveillance [24]. Compared to TAS, MX has the advantages of being non-invasive
to humans, and potentially more cost-effective in some settings. However, MX requires ento-
mological expertise for trapping and processingmosquitoes, and laboratories capable of
conducting large scale molecular diagnostics. In addition, there are currently unanswered ques-
tions about sampling strategies, limited evidence to inform the translation of MX results into
operational strategies, and no clear guidelines on the thresholds of DNA prevalence that should
be used to indicate likely ongoing transmission. Cut-off points of 0.25%, 0.5%, and 1% have
been suggested for Culex areas [8,12,25], and 0.085% for L3 and 0.65% for any larval stage for
Anopheles areas [13]. There are currently no clear recommendations for Aedes areas, but a pro-
visional threshold of<0.1% has been suggested [26]. The lower the estimated cut-off points,
the larger the sample sizes of mosquitoes that will be required for MX.
As part of the PacELF, American Samoa has made significant progress toward reducing LF
infection rates. After seven rounds of MDA from 2000 to 2006, antigen prevalence in humans
dropped from 16.5% (N = 3018) in the 1999 baseline assessment to 2.3% (N = 1881) in 2007 in
a community cluster survey [27]. American Samoa passed TAS in 2011–2012 and again in
2015, but recently published studies using spatial analysis of antigen prevalence in adults [7]
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and molecular xenomonitoring [28] showed evidence of possible ongoing transmission. By
linking the results of the published human and mosquito studies, we aim to evaluate MX as a
surveillance tool in the post-MDA setting in American Samoa, an Aedes transmission area in
the Pacific Islands.
Methods
Study location and setting
American Samoa is a US Territory in the South Pacific, consisting of a group of small tropical
islands with a total population of 56,000 [29] living in 67 villages. Over 90% of the population
live in small villages on the main island of Tutuila, and the remainder on the adjacent island of
Aunu’u and the remote Manu’a group of islands (Ta’u, Ofu, and Olosega).W. bancrofti is the
only species of human filarial worm known to be present in American Samoa. The main vector
is the highly efficient day-biting Ae. polynesiensis, and other vectors includeAe. samoanus
(night-biting),Ae. tutuilae (night-biting), and Ae. upolensis (day-biting) [30–32].
Human infection data
Data were obtained from a published study on the seroprevalence and spatial epidemiology of
lymphatic filariasis in American Samoa [7]. The study used samples from a serumbank col-
lected fromMay to August 2010 for a leptospirosis study; the study design has been published
previously [33,34]. Briefly, the study included 807 adults (aged 18 to 87 years, 52.4%males)
from 659 households in 55 villages on all five inhabited islands of American Samoa. Sampling
was designed to provide a representative sample of the adult population in American Samoa,
in both age and geographic distribution. Using these 2010 samples, a seroprevalence study was
conducted in 2013 [7], and found that 3.2% were seropositive for Og4C3 Ag, and 8.1% and
17.9% were seropositive for Wb123 Ab and Bm14 Ab, respectively [7]. The study also found
significant spatial clustering of Ag-positive persons; average cluster size was 1,498m in diame-
ter for those with Og4C3 Ag>32 units, and the proportion of the variation explained by geo-
graphic proximity was 62%. Higher infection rates were found in males and recent migrants to
American Samoa. Antigen (Og4C3) positivity indicates the presence of adult worm antigen but
does not provide information on the viability, e.g. the worm could be alive or dead, or there
could be a single sex worm infection or sterile worm infection. The presence of Og4C3 Ag rep-
resents current or recent infection. The presence of antibodies represents current or past infec-
tion, possibly many years in the past.
For our study, human data were summarized by village and the following variables were
generated:
• Total number of people sampled from each village
• Village-level seroprevalence (point estimates and 95% CI) for Og4C3 Ag, Wb123 Ab and
Bm14 Ab,
• Seropositive village for Og4C3 Ag, Wb123 Ab, and Bm14 Ab (defined as villages with at least
one seropositive person)
A village-level summary of the human serological data is provided in S1 Appendix.
Molecular xenomonitoring data
Schmaedick et al conducted a MX study in American Samoa from February to June 2011,
approximately 9 months after the above human serum specimens described above were
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collected.Detailed descriptions of the study and its findings have been published [28], and a
village-level summary is provided in S1 Appendix. Briefly, mosquitoes were collected from 34
randomly selected villages on the island of Tutuila, the only village on Aunu’u, all five villages
on the Manu’a Islands, and the village of Ili’ili (on Tutuila) where two ICT-positive children
were identified during the 2011 TAS. Up to 10 traps were placed in each village for 24 to 48
hours, and mosquitoes were removed from traps twice daily. The study collected a total of
22,014 female mosquitoes of Aedes and Culex genera that were sorted into 2,629 pools of20
mosquitoes (range 1 to 20) for PCR testing. Real-time PCR was conducted using primers
designed to amplify a fragment ofW. bancrofti [35]. A positive PCR result indicates the pres-
ence of filarial worm DNA, but does not provide any information on whether the worms are
alive or transmissible. Each pool included only one mosquito species, except for the Ae. (Fin-
laya) group of species (Ae. oceanicus, Ae. samoanus, and Ae. tutuilae) which were combined
for PCR testing because of morphological similarities. The MX study calculatedmaximum
likelihood point estimates of the prevalence of PCR-positive Ae. polynesiensis for each village
or village group using PoolScreen software (version 2.0.3), which takes into account the aver-
age number of mosquitoes per pool and the proportion of pools that were PCR-positive. Point
estimates of village-level prevalence of PCR-positive Ae. polynesiensis ranged from 0% to 2.8%
for villages on Tutuila and Aunu’u, and was 0% for all villages in the Manu’a islands. The find-
ings indicated widespread presence of filarial DNA in the mosquito population, suggesting
persistent low-level transmission of LF on Tutuila and Aunu’u. [27]
For our study, mosquito data were summarized for each village for i) Ae. polynesiensis, and
ii) other mosquito species (all species apart from Ae. polynesiensis), and iii) any mosquito spe-
cies. Entomological data available by village included number of traps used; number of females
and pools of each mosquito species; number of PCR-positive pools of each species; and esti-
mated prevalence of PCR-positive Ae. polynesiensis (using PoolScreen software).
Ethical considerations
This study used de-identified data from the two previously published studies described above
[7,28]. The human study only included adults, and written informed consent was obtained
from each participant. The American Samoa Institutional ReviewBoard (IRB) provided
approval for the use of the human serumbank for lymphatic filariasis research.
Data analysis
In the MX study, some small adjacent villages were combined into groups of two to four vil-
lages for trapping and analyses, and human data were grouped accordingly to match the ento-
mological data. Human data were not available for three of the villages included in the MX
study. For this study, analyses were limited to the villages or village groups where both human
data and MX data were available for 32 locations: 23 individual villages on Tutuila, 3 village
groups (of two villages each) on Tutuila, the only village on Aunu’u, and all five villages on the
Manu’a Islands. The 32 villages and village groups will be referred to as “villages” from here for
ease of reference.
Chi-squared tests and logistic regression were used to identify associations between seroposi-
tive humans and PCR-positive mosquito pools, and answer the following operational questions:
• Is the presence of PCR-positive pools of Ae. polynesiensis in a village a useful indicator of a
seropositive village? If so, how accurate are PCR-positive pools for predicting seropositive vil-
lages for Og4C3 Ag, Wb123 Ab, and Bm14 Ab?
Molecular Xenomonitoring in American Samoa
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• Is the presence of PCR-positive pools of Ae. polynesiensis a better indicator of seropositive
villages than PCR-positive pools of other mosquito species, or PCR-positive pools of any
mosquito species? In other words, do the time, effort, and expertise required to separate mos-
quitoes into species-specificpools improve the accuracy of the predictions?
• Is the estimated prevalence of PCR-positive Ae. polynesiensis (calculated by PoolScreen) a
better indicator of the above measures? In other words, is it necessary to estimate prevalence
using PoolScreen, or does the presence/absence of PCR-positive pools provide equally accu-
rate predictions?
Results
Serological results from 376 persons residing in 32 villages were included in the analyses. The
average number of persons per village was 13.9 (range 2–73) for Tutuila and Aunu’u, and 14.0
(range 11–16) for the Manu’a Islands.
Table 1 provides a summary of the number of seropositive persons and village-level sero-
prevalence for each serologicalmarker in humans, and the entomological data used in this
study. Of the 32 villages included in this study, 11 (34.4%) had residents who were seropositive
for Og4C3 Ag, 18 (56.3%) for Wb123 Ab, and 27 (84.4%) for Bm14 Ab. On Tutuila and
Aunu’u, village-level seroprevalence ranged from 0% to 33.3% for Og4C3 Ag, 0% to 66.7% for
Wb123 Ab, and 0% to 100% for Bm14 Ab. In the Manu’a Islands, no individuals were seroposi-
tive for Og4C3 Ag, and village-level seroprevalence ranged from 0% to 18.8% for Wb123 Ab,
and 13.3% to 27.3% for Bm14 Ab. On Tutuila and Aunu’u, the MX study identified PCR-posi-
tive pools of Ae. polynesiensis in 15 (55.6%) of the 27 villages included in this study, of other
mosquito species in 7 (25.9%) villages, and of mosquitoes of any species in 17 (63.0%) of the
villages. In the five villages on the Manu’a Islands, no PCR-positive pools of mosquitoes were
identified during the MX study.
Association between PCR-positive mosquito pools and seropositive
villages
Associations between the presence of PCR-positive pools of mosquitoes and seropositive vil-
lages and are shown in Table 2, with analyses stratified for i) Ae. polynesiensis only, ii) for all
other mosquito species and iii) for mosquitoes of any species. Chi-squared tests of association
showed that PCR-positive pools of Ae. polynesiensis (p 0.001) and PCR-positive pools of any
species (p = 0.002), but not pools of other species, were significantly associated with seroposi-
tive villages for Og4C3 Ag andWb123 Ab, but not Bm14 Ab.
Fig 1 shows that the presence of at least one PCR-positive pool of Ae. polynesiensis or of any
species was associated with a significantly higher probability of identifying a village with inhab-
itants seropositive for Og4C3 Ag (p< 0.001 and p = 0.002) andWb123 Ab (p = 0.001 and
p = 0.002). In the 15 villages with at least one PCR-positive pool of Ae. polynesiensis, 10 (67%)
were seropositive for Og4C3 Ag and 13 (87%) were seropositive for Wb123 Ab, compared to
6% and 29% of villages respectively, where PCR-positive pools were not identified. Similarly, in
the 17 villages where at least one PCR-positive pool of any species were identified, 11 (59%)
had inhabitants who were seropositive for Og4C3 Ag and 14 (82%) with persons seropositive
for Wb123 Ab, compared to 7% and 27% of villages respectively, with no PCR-positive pools.
The presence of PCR-positive pools was not significantly associated with seropositivity for
Bm14 Ab. PCR-positive pools of other mosquito species were not significantly associated with
seropositive villages for any of the serologicalmarkers.
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Predicting the location of seropositive villages by using the presence of
PCR-positive pools of mosquitoes
Table 3 provides a summary of the accuracy of PCR-positive mosquito pools for predicting
seropositive villages for each antigen and antibody. PCR-positive pools of Ae. polynesiensis pro-
vide a sensitivity of 90.9% and specificity of 76.2% for identifying villages with seropositive per-
sons for Og4C3 Ag, with a high negative predictive value of 94.1% (i.e. absence of PCR-positive
pools was a good indicator of the absence of seropositive persons). PCR-positive pools of any
mosquito species provide the same sensitivity (90.9%) but a lower specificity (66.7%), and a
negative predictive value of 93.9%.
For Wb123 Ab, PCR-positive pools of Ae. polynesiensis provide a sensitivity of 72.2% and
specificity of 85.7%, while PCR-positive pools of any mosquito species provide a sensitivity of
77.8% and specificity of 78.6% for identifying seropositive villages. For Bm14 Ab, PCR-positive
pools of Ae. polynesiensis and any species had poor sensitivities (48.1% and 51.9%) and speci-
ficities (60.0% and 40.0%) for predicting seropositive villages.
PCR-positive pools of Ae. polynesiensis or any mosquito species were statistically significant
predictors of villages with residents seropositive for Og4C3 Ag (odds ratios of 32.0 and 20.0)
andWb123 Ab (odds ratios of 15.6 and 12.8), but not for Bm14 Ab. The correlation between
PCR-positive pools of Ae. polynesiensis and seropositive villages for Og4C3 Ag andWb123 Ab
are shown for each village in Tutuila and Aunu’u in Fig 2, and the Manu’a Islands in Fig 3.
Predicting the location of seropositive villages by using the estimated
prevalence of PCR-positive Ae. polynesiensis
In the MX study, the estimated prevalence of PCR-positive Ae. polynesiensis ranged from 0%
(95% CI 0–0.1%) to 2.8% (0.5–7.9%) on Tutuila and Aunu’u, and was 0% for all villages in the
Table 2. Association between PCR-positive pools of mosquitoes and seropositive villages for
Og4C3 Ag, Wb123 Ab, and Bm14 Ab.
Antigen/antibody
status of villages#
Number of
villages (% of
total)
Villages with PCR-
positive pools of
Ae. polynesiensis
Villages with
PCR-positive
pools of other
species
Villages with PCR-
positive pools of
any species
N (%) p value* N (%) p value* N (%) p value*
Total villages 32 (100%) 15
(100%)
7
(100%)
17
(100%)
Seropositive for
Og4C3 Ag
11 (34.4%) 10
(66.7)
<0.001 4 (57.1) 0.151 10
(58.8)
0.002
Seronegative for
Og4C3 Ag
21 (65.6%) 5 (33.3) 3 (42.9) 7 (41.2)
Seropositive for
Wb123 Ab
18 (56.3%) 13
(86.7)
0.001 6 (85.7) 0.075 14
(82.4)
0.002
Seronegative for
Wb123 Ab
14 (48.8%) 2 (13.3) 1 (14.3) 3 (17.6)
Seropositive for Bm14
Ab
27 (84.4%) 13
(86.7)
0.737 6 (85.7) 0.912 14
(82.4)
0.737
Seronegative for Bm14
Ab
5 (15.6%) 2 (13.3) 1 (14.3) 3 (17.6)
# A seropositive village is defined as a village with at least one seropositive person for the antigen or
antibody. A seronegative village is defined as a village with no seropositive persons.
*Chi-squared tests comparison of villages with presence/absence of PCR-positive mosquito pools and
presence/absence of seropositive persons. Statistically significant results highlighted in bold.
doi:10.1371/journal.pntd.0005108.t002
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Manu’a islands. Table 4 shows that a higher estimated prevalence of PCR-positive Ae. polynesien-
sis (as a continuous variable) was associated with increased odds of a seropositive village for
Og4C3 Ag andWb123 Ab, but the findings were not statistically significant with this sample size
and the level of precision inherent in PoolScreen predictions based on pooledmosquito samples.
Fig 1. Probabilities of identifying seropositive villages for Og4C3 Ag, Wb123 Ab and Bm14 Ab based on
the presence of PCR-positive pools of a) Ae. polynesiensis, b) any mosquito species, and c) other
mosquito species.
doi:10.1371/journal.pntd.0005108.g001
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Discussion
Our results show that MX is a potentially useful tool for post-MDA surveillanceof lymphatic
filariasis in American Samoa. The presence of PCR-positive pools of Ae. polynesiensis was
found to be a good predictor of villages with persons seropositive for Og4C3 Ag andWb123
Ab, but not Bm14 Ab. Bm14 Ab can persist for many years or decades after initial infection but
does not necessarily persist for life, and antibody levels can also decline or be cleared after
MDA [36,37]. Wb123 Ab can also persist for many years after initial infection, and declines
after MDA [38]. Currently, there is insufficient data on the relative rates of antibody decay or
clearance, but it is thought that Wb123 Ab responses decay more rapidly than Bm14 Ab. Bio-
logically, Wb123 Ab responses might increase earlier because they are against a larval antigen
and therefore also more likely to be associated with mosquito exposure. In our study, the lack
of association between PCR-positive pools of mosquitoes and Bm14 Ab was therefore not
unexpected, but the association withWb123 Ab could be related to earlier appearance or faster
disappearance of Wb123 Ab than Bm14 Ab during and after active infections, respectively
[39–41].
In American Samoa, where ~75% of mosquitoes collected in the entomology study (using
BG Sentinel traps) were Ae. polynesiensis, the presence of PCR-positive pools of eitherAe.
Table 3. PCR-positive pools of mosquitoes as predictors of villages with inhabitants seropositive
for Og4C3 Ag, Wb123 Ab, and Bm14 Ab.
Any PCR-
positive
pools
Sensitivity Specificity Positive
predictive
value
Negative
predictive
value
Odds
ratio*
(95%
CI)
p
value*
a)
Seropositive
villages for
Og4C3 Ag
Ae.
polynesiensis
90.9% 76.2% 66.7% 94.1% 32.0
(3.2–
315.3)
0.003
Other
mosquito
species
36.4% 85.7% 57.1% 72.0% 3.43
(0.6–
19.4)
0.163
Any mosquito
species
90.9% 66.7% 58.8% 93.3% 20.0
(2.1–
189.2)
0.009
b)
Seropositive
villages for
Wb123 Ab
Ae.
polynesiensis
72.2% 85.7% 86.7% 70.6% 15.6
(2.5–
96.1)
0.003
Other
mosquito
species
33.3% 92.9% 85.7% 52.0% 6.5
(0.7–
62.1)
0.104
Any mosquito
species
77.8% 78.6% 82.4% 73.3% 12.8
(2.4–
69.7)
0.003
c)
Seropositive
villages for
Bm14 Ab
Ae.
polynesiensis
48.1% 60.0% 86.7% 17.6% 1.4
(0.2–
9.7)
0.738
Other
mosquito
species
22.2% 80.8% 85.7% 16.0% 1.1
(0.1–
12.2)
0.912
Any mosquito
species
51.9% 40.0% 82.4% 13.3% 0.7
(0.1–
5.0)
0.738
*Odds ratio of seropositive village if PCR-positive mosquitoes were identified (logistic regression), and
associated p value (statistically significant results highlighted in bold).
doi:10.1371/journal.pntd.0005108.t003
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polynesiensis alone or any mosquito species provided similar predictive accuracy of identifying
villages with residents seropositive for Og4C3 Ag or Wb123 Ab. Our study shows that in this
setting, separation of mosquito species for MX did not improve the predictive accuracy for
identifying villages with seropositive inhabitants. However, it is important to point out that our
results would have been different if we had used traps with a different level of selectivity for Ae.
polynesisensis. MX studies in locations with other vector species and employing different traps
may require sorting of mosquito species to achieve optimal results.
The presence of PCR-positive pools of Ae. polynesiensis or mosquitoes of any species had
high sensitivity and high negative predictive value (both>90%) for correctly identifying
Fig 2. Associations between PCR-positive pools of Ae. polynesiensis and seropositive villages for
Og4C3 Ag and Wb123 Ab on Tutuila and Aunu’u.
doi:10.1371/journal.pntd.0005108.g002
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Fig 3. Association between PCR-positive pools of Ae. polynesiensis and seropositive villages for
Og4C3 Ag and Wb123 Ab on the Manu’a Islands.
doi:10.1371/journal.pntd.0005108.g003
Table 4. Association between estimated prevalence of PCR-positive Ae. polynesiensis (using
PoolScreen) and seropositive villages for Og4C3 Ag, Wb123 Ab, and Bm14 Ab.
Seropositive villages for Odds ratio* 95% CI p value
Og4C3 1.76 0.51–6.03 0.367
Wb123 1.85 0.46–7.34 0.384
Bm14 0.42 0.11–1.64 0.211
* Odds ratio on logistic regression, per 1% increase in estimated prevalence of PCR-positive Ae.
polynesiensis (calculated using PoolScreen).
doi:10.1371/journal.pntd.0005108.t004
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villages with antigen-positive persons. These are both important for post-MDA surveillance
because tests should have a high probability of identifying residual foci of transmission (when
prevalence is very low) and low probability of missing these foci. In this study, the estimated
prevalence of PCR-positive Ae. polynesiensis (using PoolScreen) was no more useful than the
presence/absence of PCR-positive pools, but the sampling design (small number of persons in
some villages) might have limited the ability to detect significant associations.
Previous studies in three sentinel villages in American Samoa showed that MX could be a
useful tool in post-MDA surveillance [11,18]; our larger study of 32 villages corroborates those
conclusions. Our findings also suggest that in American Samoa, it is appropriate to conduct
post-MDA surveillance at the village level. This is biologically plausible considering that the
main vector, Ae. polynesiensis, has a relatively short flight range of about 100 metres [17], and
village residents are generally quite mobile within their own village, e.g. visiting homes of fam-
ily and friends, sharing outdoor spaces, attending school and church, and shopping at local
stores. Further interventions (e.g. further targetedMDA or a test and treat approach) could
also be conducted at the village or even sub-village level.
The results should be considered in light of the study’s limitations. The study was based on
serological data from humans; microfilaria results were not available because the study was
conducted using a pre-existing serumbank. Human serological data and entomological data
were sourced from previously published studies, and there was a time lag of approximately
nine months between the human and entomology studies. Sampling of the human seropreva-
lence study was designed to maximise spatial dispersion for the purposes of predictive risk
mapping for the original leptospirosis study [7], resulting in small numbers of subjects in some
villages and wide confidence intervals for the village-level LF seroprevalence estimates. The
serumbank only included samples from adults (aged 18 years); a study that focused on or
only included children might produce different results regarding the usefulness of serological
markers, e.g. there could be significant associations between PCR-positive mosquitoes and
Bm14 Ab in children.Ae. polynesiensis, the primary vector in American Samoa, is a day-biting
mosquito; our human data were summarised by village of residence, and it is possible that
PCR-positive mosquitoes acquired infections from residents of other villages who visited dur-
ing day time.
Despite the study’s limitations, we were able to identify statistically significant associations
betweenMX data and human seroprevalence data at the village level. Further studies specifi-
cally designed to assess the usefulness of MX in the post-MDA setting might produce results
with even stronger associations.With higher resolution data, it is also potentially possible to
determine thresholds for the prevalence of PCR-positive Ae. polynesiensis at which further
interventions (e.g. repeatingMDA or more intensive surveillance) are recommended. In Amer-
ican Samoa, LF transmission is dominated by Ae. polynesiensis; studies in other countries with
a different mix of vector mosquitoes will be needed to determine whether separation of mos-
quitoes by species is necessary for MX.
This exploratory study provides promising evidence to support the potential usefulness of
MX in post-MDA surveillance in an Aedes transmission area in a Pacific Island setting to pre-
dict sub-national areas where LF transmission may still be occurring.Although American
Samoa has successfully completed MDA and passed two TAS of 6–7 year old children,
there is evidence of ongoing low-level transmission of LF. Our findings demonstrated that in
this setting, MX was useful for localising residual areas of focal transmission and could
potentially be used to inform the need for additional elimination activities. Our study also
highlights that assessment of antigen prevalence in adults in post-MDA surveillance could
complement TAS and provide valuable information for informing programmatic decisions
in the endgame.
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